# Proof of Mechanism of a New Ketogenic Supplement Using Dual Tracer PET (Positron Emission Tomography)

> **NCT02551419** · NA · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 82 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DIETARY_SUPPLEMENT:** ketogenic drink
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT02551419
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2020-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551419, "Proof of Mechanism of a New Ketogenic Supplement Using Dual Tracer PET (Positron Emission Tomography)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02551419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*